HomeNews & TopicsResearchCOVID-19 in pregnancy associated with adverse outcomes for mother and baby

COVID-19 in pregnancy associated with adverse outcomes for mother and baby

Published on

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in pregnancy is associated with preeclampsia, stillbirth, preterm birth and other adverse outcomes, found new research published in CMAJ (Canadian Medical Association Journal).

“Our findings suggest that pregnant people with COVID-19 have an increased risk of high blood pressure, stillbirth and preterm birth. Their newborns are more likely to need intensive care. Pregnant people with severe COVID-19 symptoms have a particularly high risk of these complications,” says Dr. Nathalie Auger, Department of Social and Preventive Medicine, School of Public Health, University of Montreal, Montréal, Quebec, with coauthors.

Researchers reviewed 42 studies involving 438 548 pregnant people from around the world to determine the association between SARS-CoV-2 infection and adverse pregnancy outcomes. They found double the risk of preterm birth and a 50% increased risk of cesarean delivery in pregnant people with symptomatic COVID-19 than in those with asymptomatic COVID-19. Those with severe COVID-19 had a 4-fold higher risk of high blood pressure and preterm birth.

The reason for the increased risk of adverse outcomes is unclear, but could be because SARS-CoV-2 may lead to vasoconstriction and stimulate an inflammatory response affecting blood vessels.

The findings of this systematic review differ from prior findings from case reports and case series. “Our meta-analysis of recent good-quality cohort studies with comparative data does not align with these previous reviews, and provides clear evidence that symptomatic or severe COVID-19 is associated with a considerable risk of preeclampsia, preterm birth and low birth weight,” write the authors.

“Clinicians should be aware of these adverse outcomes when managing pregnancies affected by COVID-19 and adopt effective strategies to prevent or reduce risks to patients and fetuses,” they conclude.

The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis” was published March 19, 2021.

Latest articles

The Cost of Silence: Why Black Youth Mental Health Can’t Wait

When we talk about mental health in Canada, the general numbers often hide a...

Iron deficiency anemia – demystifying a common, treatable and preventable public health problem

Over 830,000 Canadians have iron deficiency anemia (IDA),1 the most common cause of anemia.2...

Women living with Parkinson’s are overlooked and under-researched

Nearly half of Parkinson’s diagnoses are women, yet their care, support and research is...

Antibiotic resistance in Canada: What you can do

It’s normal to want quick relief when you’re sick fighting an infection. Antibiotics seem...

More like this

A new home for Canada’s largest Cancer Research Tumour Bank

Decades of cancer research — and thousands of patient tumour samples — now have...

Equity-focused study on immigrant kidney disease risk

HN Summary • A new SHN-led study published in BMJ Open reveals significant disparities in...

Shorter duration of antimicrobial therapy in common infections

HN Summary • Growing evidence shows that shorter courses of antibiotics are just as effective...

Global clinical trial exploring potential treatment for sickle cell disease

HN Summary • SHN is leading a global clinical trial testing tebapivat, an investigational oral...

Lithium study yields insights in the fight against HIV

Study in human cells finds low-cost drug keeps virus dormant through an unexpected pathway,...

Gene mutation in blood-forming cells may improve cancer immunotherapy results

Researchers at UHN’s Princess Margaret Cancer Centre have found that inactivation of the TET2...